Guarini A - Search Results

1

Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Foà R, Vitale A, Vignetti M, Meloni G, Guarini A, De Propris MS, Elia L, Paoloni F, Fazi P, Cimino G, Nobile F, Ferrara F, Castagnola C, Sica S, Leoni P, Zuffa E, Fozza C, Luppi M, Candoni A, Iacobucci I, Soverini S, Mandelli F, Martinelli G, Baccarani M; GIMEMA Acute Leukemia Working Party. Foà R, et al. Among authors: guarini a. Blood. 2011 Dec 15;118(25):6521-8. doi: 10.1182/blood-2011-05-351403. Epub 2011 Sep 19. Blood. 2011. PMID: 21931113 Free article. Clinical Trial.

2

Interleukin 2 in the management of hematologic malignancies.

Foà R, Meloni G, Guarini A, Vignetti M, Mandelli F, Gavosto F. Foà R, et al. Among authors: guarini a. Pharmacol Res. 1992 Sep;26 Suppl 2:82-3. doi: 10.1016/1043-6618(92)90610-n. Pharmacol Res. 1992. PMID: 1409333 No abstract available.

3

Has IL2 a role in the management of minimal residual disease for acute leukemia?

Foa R, Meloni G, Guarini A, Mandelli F, Gavosto F. Foa R, et al. Among authors: guarini a. Leukemia. 1992 Nov;6 Suppl 4:92-4. Leukemia. 1992. PMID: 1434844 Review.

4

IL2 treatment for cancer: from biology to gene therapy.

Foa R, Guarini A, Gansbacher B. Foa R, et al. Among authors: guarini a. Br J Cancer. 1992 Dec;66(6):992-8. doi: 10.1038/bjc.1992.400. Br J Cancer. 1992. PMID: 1457368 Free PMC article. Review.

5

Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findings.

Foa R, Meloni G, Guarini A, Vignetti M, Marchis D, Tosti S, Tos AG, Vischia F, Mandelli F, Gavosto F. Foa R, et al. Among authors: guarini a. Leukemia. 1992;6 Suppl 3:115S-116S. Leukemia. 1992. PMID: 1602806

6

Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: a pilot study.

Meloni G, Foà R, Tosti S, Vignetti M, Mancini F, Guarini A, Marchis D, Gavosto F, Mandelli F. Meloni G, et al. Among authors: guarini a. Leukemia. 1992 Aug;6(8):780-5. Leukemia. 1992. PMID: 1640729

7

Defective lymphokine-activated killer cell generation and activity in acute leukemia patients with active disease.

Foa R, Fierro MT, Cesano A, Guarini A, Bonferroni M, Raspadori D, Miniero R, Lauria F, Gavosto F. Foa R, et al. Among authors: guarini a. Blood. 1991 Aug 15;78(4):1041-6. Blood. 1991. PMID: 1868239 Free article.

8

Peripheral blood and bone marrow immunophenotypic and functional modifications induced in acute leukemia patients treated with interleukin 2: evidence of in vivo lymphokine activated killer cell generation.

Foa R, Guarini A, Gillio Tos A, Cardona S, Fierro MT, Meloni G, Tosti S, Mandelli F, Gavosto F. Foa R, et al. Among authors: guarini a. Cancer Res. 1991 Feb 1;51(3):964-8. Cancer Res. 1991. PMID: 1988139

9

Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease.

Foa R, Massaia M, Cardona S, Tos AG, Bianchi A, Attisano C, Guarini A, di Celle PF, Fierro MT. Foa R, et al. Among authors: guarini a. Blood. 1990 Jul 15;76(2):393-400. Blood. 1990. PMID: 2114936 Free article.

10

Treatment of residual disease in acute leukemia patients with recombinant interleukin 2 (IL2): clinical and biological findings.

Foa R, Meloni G, Tosti S, Novarino A, Fenu S, Guarini A, Cardona S, Gillio Tos A, Gavosto F, Mandelli F. Foa R, et al. Among authors: guarini a. Bone Marrow Transplant. 1990 Jul;6 Suppl 1:98-102. Bone Marrow Transplant. 1990. PMID: 2202476 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

447 results

Search Page